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Abstract
Background: Globally, healthcare systems face major challenges with medicines management and medication
adherence. Medication adherence determines medication effectiveness and can be the single most effective
intervention for improving health outcomes. In anticipation of growth in eHealth interventions worldwide, we
explore the role of eHealth in the patients’ medicines management journey in primary care, focusing on personalisation
and intelligent monitoring for greater adherence.
Discussion: eHealth offers opportunities to transform every step of the patient’s medicines management journey.
From booking appointments, consultation with a healthcare professional, decision-making, medication dispensing,
carer support, information acquisition and monitoring, to learning about medicines and their management in daily life.
It has the potential to support personalisation and monitoring and thus lead to better adherence. For some of these
dimensions, such as supporting decision-making and providing reminders and prompts, evidence is stronger, but for
many others more rigorous research is urgently needed.
Conclusions: Given the potential benefits and barriers to eHealth in medicines management, a fine balance needs to
be established between evidence-based integration of technologies and constructive experimentation that could lead
to a game-changing breakthrough. A concerted, transdisciplinary approach adapted to different contexts, including
low- and middle-income contries is required to realise the benefits of eHealth at scale.
Keywords: Apps, eHealth, mHealth, Drug monitoring, Information communication technology, Medication adherence,
Medication therapy management, Text message
Background
Up to half of medicines prescribed for long-term condi-
tions are not taken as recommended [1, 2]. An estimated
US$375 billion per year could be saved with improved
medication adherence [3], which could prove to be one
of the most effective interventions for improving health
outcomes [4, 5]. Reasons for non-optimal use of medi-
cines are multifactorial and may be related to patient,
therapy, disease or health system issues [6]. Numerous
studies have aimed to improve medication adherence by
addressing factors such as health literacy, lack of motiv-
ation or understanding, trust in the physician, health be-
haviour, cognitive factors such as forgetfulness, and
others [7–10].
With regards to the patient, barriers to effective medi-
cines management in chronic illnesses are multifactorial;
medication adherence can be intentional or uninten-
tional [11–14]. Unintentional non-adherence arises due
to several inter-related factors, including inability to
keep up with medication dosing schedules, long duration
and complexity of medication regimens, miscommunica-
tion, and capacity limitations such as physical disabilities
and financial constraints [11, 14]. Intentional non-
adherence is a more complex problem and involves pa-
tients choosing not to take their medications as pre-
scribed due to various behavioural, attitudinal and
socioeconomic reasons [11, 15]. Several interventions
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have shown to improve medication adherence [16], but
most at best by only 10 percentage points [16, 17]. Very
few interventions have been implemented at a large scale
as these interventions are typically complex, labour in-
tensive and costly [18].
We conducted a literature review on topics related to
eHealth and medicines management on PubMed. Confer-
ence proceedings and national guidelines were also
searched. This paper is not a systematic review of litera-
ture, but a summarised discussion of eHealth in the pa-
tients’ medicines management journey. In this discussion,
we explore the role that eHealth (the use of a wide range
of information and communication technologies for
health) (Table 1) could play in primary care, outpatient
and community medicines management, focusing on how
more personalisation and more intelligent monitoring
could lead to greater adherence (Fig. 1).
The patient’s medicines management journey
The medicines management process usually starts
when the patient first gains access to a healthcare
provider, and jointly decides with the prescriber on
the prescription during a clinical consultation. After
obtaining the medicines at a pharmacy, the patient
must integrate the process of medication taking into
their daily routine. Non-adherence can occur when
the patient does not take the first dose, does not con-
tinue with the prescribed treatment at the approriate
frequency or dose, or does not continue taking the
medicines after a period of time [19].
Table 1 eHealth technologies and their application in medicines management
eHealth technology What is it? Application in medicines management
Electronic health records
(EHRs)
EHRs are real-time, patient-centred records that provide
immediate and secure information to authorised users. EHRs
typically contain a patient’s medical history, diagnoses and
treatment, medications, allergies, immunisations, as well as
radiology images and laboratory results. A national EHR
system is most-often implemented under the responsibility
of a national health organisation and will typically make a
patient’s medical history available to health professionals in
healthcare institutions and provide linkages to related
services such as pharmacies, laboratories, specialists, and
emergency and medical imaging facilities [62]
History taking, recording and decision support for medicines
management
Telehealth Telehealth refers to the delivery of healthcare services,
where patients and providers are separated by distance.
Telehealth uses information communication technologies
for the exchange of information for the diagnosis and
treatment of diseases and injuries, research and evaluation,
and for the continuing education of health professionals. It
is particularly valuable for those in remote areas, vulnerable
groups and aging populations [63]
Remote consultations including exchange of information on
chronic disease care and medicines management [64]
Web-based monitoring
system
Web-based monitoring systems are internet-based websites
developed to monitor and/or to deliver tailored educational
content related to a health condition
Monitoring of medication adherence and education on the
chronic disease, including the required medication (e.g.
asthma) [65]. May/may not provide a communication
platform for patients with their healthcare providers [39]
Short messaging service
(SMS)
SMS, or text messaging, is used as a communication tool to
exchange short messages over the phone, web or mobile
communication system. It is a low-cost method to promote,
inform or remind patients on information relating to their
health or healthcare. It can also be used as a tool to
facilitate communication of health messages between
patients and healthcare providers [36]
Tailored or standardised medicine taking reminders with
either one way or two-way interactions. Studies have shown
improvement in medication adherence, but more high
quality studies are required to establish evidence in this
area [66]
Mobile health apps Mobile apps are software applications designed to run on
portable devices such as smartphone or tablet computers.
Health apps are designed for a multitude of purposes such
as data collection, health and disease education, disease
and lifestyle management, surveillance, monitoring and
health promotion to support the management of one’s
health
Personalised reminders; medicines organisation;
polypharmacy management; integration of medicines taking
as part of chronic disease management; information
exchange on medicines; medication refill orders
Wearable devices Wearable devices are gadgets embedded with electronics,
software or sensors that can be worn as clothing or
accessories. Wearable devices are also examples of Internet
of Things, where a network of sensors can perform data
exchange across platforms. These devices are useful for
round-the-clock monitoring and can collect real-time data
through location and activity tracking
App-linked devices with sensors can be worn to alert
asthma patients of impending asthma attacks, for better
medicines management [67]. Biosensors such as wearable
patches or contact lenses can continuously measure blood
glucose for better insulin management [68]; however, the
efficacy and cost-effectiveness of these devices have yet to
be established
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Access to healthcare providers
eHealth is changing conventions for how patients con-
sult their health providers. For an ever growing number
of scenarios, face-to-face consultations that were once
the norm are being supplemented or replaced with a
range of synchronous or asynchronous remote consult-
ing approaches via text, voice or video. For example, it
might be suggested that the review of medication for pa-
tients with a chronic illness that does not require phys-
ical examination can be done remotely, patients with
concerns about accidental overdosing can phone for ad-
vice, and less urgent queries can be made through an
email or web portal. Remote consulting does not just
improve convenience and access, save travel and waiting
time, but also removes geographical distances and po-
tentially reduces socioeconomic gaps.
Automated telephone communication systems (ATCS)
can deliver pre-recorded voice messages from healthcare
providers to patients through the telephone’s touch-tone
keypad or via voice-recognition software. ATCS have
been shown to provide remote, round-the-clock access
to healthcare advice for patients with lower socio-
economic backgrounds, and are able to facilitate self-
monitoring in various chronic diseases such as diabetes,
heart failure and hypertension, although the evidence is
mixed [20].
Appointment scheduling and reminders for medica-
tion reviews can equally benefit from these technologies
[21, 22]. The key challenge is to provide seamless inte-
gration into health systems to enable discrete, yet effect-
ive communication of prompts and reminders, and
increase flexibility to change scheduled appointments ef-
fortlessly if required. Few health systems have achieved
this at scale and made it routine care. Yet, both in terms
of evidence and technology, there are few barriers to
make it happen other than the redesign of older, less ef-
fective, processes. This should be realised, as with all
(e)health interventions, within the framework of con-
tinuous evaluation to ensure further improvement and
learning.
The options for eHealth technologies are expected to
further expand to allow more flexibility in accessing
healthcare. Smartphones are increasingly all-pervading
healthcare tools, able to offer health advice at just a ‘tap’
away. Medicines can also be ordered through a smart-
phone app and delivered to patients’ homes. Moving for-
ward, there is a need to establish evidence for the right
balance in use of these novel technologies. Outcomes,
such as quality and safety of care, cost-effectiveness, ac-
ceptability, fidelity, etc., all need to be rigorously evalu-
ated in order to understand how best to reap the
potential benefits while minimising potential limitations.
Clinical consultations
When patients enter the privacy and uniqueness of hu-
man trust in a medical consultation, what follows is a
Fig. 1 Role of eHealth in enhancing personalisation and monitoring in patients’ medicines management journey
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careful history taking, examination and investigation,
diagnosis and review, as needed. Further to making a
diagnosis or review, the physician or other healthcare
professional will explain to the patient their treatment
options and discuss the disease and medicines manage-
ment. In the past, patients were expected to follow doc-
tors’ choices and recommendations, including those
relating to medicines, without active involvement in
decision-making. Today, it is recognised that personalis-
ing healthcare within a shared decision-making frame-
work leads to better outcomes, patient engagement and
increases the level of trust between providers and pa-
tients [23].
eHealth is able to improve pre-consultation medical
history taking by digitising information acquisition for
history taking via Computer Assisted History Taking
Systems (CAHTS). The use of CAHTS has the potential
to improve quality and comprehensiveness of informa-
tion captured, reduce data entry errors, save time and fa-
cilitate acquisition of sensitive patient information [24].
It can be used from the convenience of home, while
travelling, or while in the waiting room. CAHTS can
collect information on medication history, adherence
and possible side effects, and can use decision support
trees in data capture, etc. It is more effective than face-
to-face consultation in capturing sensitive information
(e.g. about sexually transmitted diseases, or mental ill-
ness). Use of CAHTS will increase in the coming years
as it advances in sophistication and becomes more rou-
tinely adopted within healthcare.
eHealth is transforming decision-making, information
sharing and patient education. Within medication man-
agement, electronic health records (EHRs), computerised
prescription order entry (CPOE) and computerised deci-
sion support systems (CDSS) are now considered the
norm in many health systems, albeit with scope for fur-
ther development [25]. For example, CDSS can improve
patient safety through checks for drug allergies and
drug-drug interactions, and by providing evidence-based
recommendations and prescribing guidelines. Direct
transmission of prescriptions to the pharmacy can also
reduce transcription errors. Relevant information on the
individual’s current and past prescriptions, or medicines
taking behaviour, can support personalisation of care by
informing providers about potential non-adherence and
contraindicated therapies. Patient education and medi-
cines management plans can then be tailored to focus
on individual needs, which is more likely to support ad-
herence to planned treatment.
Dispensing of medication
Similar to the flight attendants’ pre-flight cross-checking
of an aircraft’s doors, the pharmacy acts as a cross-check
for the prescriber by ensuring the medications
prescribed are safe in terms of dose, frequency and the
presence of other medications, and appropriate for the
patient according to their illness and medication history.
In the future, we anticipate that eHealth could support
and further this cross-checking function. Prior to dis-
pensing the medication at the pharmacy, using inter-
active technology, eHealth solutions could check for
patients’ understanding of medications based on what
was conveyed by the doctor during the consultation.
This could support patients’ adherence through better
patient education.
ePrescription potentially represents digitisation of both
prescribing and dispensing. With increasing automation
of dispensing, this has the potential to free up pharma-
cists’ time to spend in clinical roles such as talking to
patients to support adherence. The role of the pharma-
cist is increasingly shifting from medication dispensing
to the automation of pharmacy dispensing functions
[26]. In addition to the ability to reduce transcription er-
rors through electronic transmission of orders from the
prescriber to the pharmacy, ePrescribing solutions can
also support medication reconciliation, remote monitor-
ing of adherence through refill tracking, and issuing of
automatic refill alerts [27]. Patients can also benefit from
a seamless medication refill process and the convenience
of home delivery of medications. In many high-income
countries, ePrescription has transformed prescribing and
dispensing with automated decision support. Health sys-
tems that allow prescribers and pharmacists to access
the information pertaining to an individual’s prescrip-
tions, and support the prescription of formulary alterna-
tives such as generic drugs, could lower the cost to
patients and healthcare systems. Although the technol-
ogy is mature, adoption among solo or small primary
care practices is still low in third-party payer systems
such as the USA [28]. Being able to expand coverage in
the future to span the entire health economy will also
prevent medication safety issues that arise as a result of
care fragmentation. On the other hand, some countries
do not have healthcare organisations that are supported
by an interoperable information technology network. Al-
though CPOE systems can be standalone, the issue of
fragmentation of medication records could act as a bar-
rier towards reaping the full benefits of an integrated IT
system. This could change in the future with greater in-
tegration of IT solutions within healthcare.
In the future, we might expect complete digitisation
and the integration of CDSS and CPOE with personal
health records and medical records to provide a more
seamless patient experience. Being able to interact with
the healthcare system via online personal health portals
has been shown to improve patients’ medication adher-
ence [29] due to the added convenience of online medi-
cation refill and also through increased awareness of
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their health status [30]. Due to the impact on revenue
and patient outcomes, the pharmaceutical industry, as
well as public and private funders, are ardently exploring
eHealth technologies to improve medicines manage-
ment. A number of pharmaceutical companies have
launched apps for medication adherence and chronic
disease medicines management, and moving towards
more partnerships with healthcare institutions to im-
prove the quality and delivery of eHealth technologies.
At the system level, with greater information integra-
tion, a self-learning IT system could be created. For ex-
ample, new information about the individual patient,
especially health behaviour data that might be captured
via wearables, can offer better identification of individuals
who need additional support or change of treatment.
Medicines management in daily life
Self-management and medicines taking occurs after the
patient leaves the pharmacy with the dispensed medi-
cine. Newly diagnosed patients learn about the medicine
(e.g. about its uses, interactions, precautions, side effects,
dosage, storage) and incorporate, with varying degrees of
success, their medicine taking into daily life routines at
home, work or while travelling.
Apart from medicines management education received
in consultation with the prescriber and the pharmacist,
patients may have subsequent questions about the medi-
cines they are taking. The internet and multimedia-rich
mobile phone applications (apps) already act as informa-
tion sources and will increasingly do so, potentially im-
proving health literacy by providing and reinforcing
education on topics such as the purpose of the medicine,
how to take it, possible side-effects and contraindications.
To reinforce adherent behaviours, electronic reminders
can alert patients to take their medication, to monitor pa-
rameters, or about upcoming appointments. Tailoring of
the frequency and timing of mobile phone text messages
is increasingly being used to remind patients of their med-
icines schedule [31]. Tailored interventions have also
shown superior outcomes in behavioural change com-
pared to standardised text messages [32]. Text messages
in studies showing a benefit were more likely to contain
educational and motivational content and/or were more
tailored to the user or their condition. More basic and re-
petitive text messages showed fewer benefits [33]. Perso-
nalised interventions based on shared decision-making
with patients are more likely to have positive outcomes, as
involving patients in deciding the time and method for re-
ceiving interventions from healthcare providers minimises
annoyance from constant notification of health messages
[34]. In addition, studies have found that receptivity to-
wards mobile phone text messages as a healthcare inter-
vention reduces with increasing age, as well as with lower
education and income levels [35]. Therefore, clinicians
and policymakers need to be cognizant of this and provide
additional strategies for certain patient groups.
Monitoring of patient outcomes and medicines taking
behaviour are important functions to achieve better ad-
herence to medicines. A survey by the WHO on mobile
health (mHealth) reported the highest percentage of pa-
tient monitoring activities in high-income countries
compared to other world regions but patient monitoring
emerged as the least established mHealth initiative des-
pite its strong potential for improving outcomes and
cutting healthcare costs [36]. A systematic review also
showed a reduction in all-cause mortality and hospital
admission by approximately 20% in patients with
chronic heart failure undergoing remote monitoring
compared to patients under usual care [37]. The process
of medicines taking can be self-monitored or performed
by the primary care provider using electronic devices.
To enable personalised self-care, smart devices, con-
sumer wearables, electronic pill boxes and applications
(device agnostic, mobile or other) should be designed to
be easy to use with customisable features. These elec-
tronic devices could then concurrently support the goal
of information gathering for healthcare decision support.
eHealth advances will continue to drive rapid progress
to close the current gaps within the medicines manage-
ment process by enhancing the speed and accuracy of
data transmission. The Internet of Things (IoT) is a con-
cept referring to networked everyday objects that inter-
connect to each other via wireless sensors attached to
them [38]. With the emergence of IoT, information on
consultations, prescriptions and medication refills can be
integrated into a centralised system combined with a
new previously non-existent category of personally col-
lected data about patients, which will allow for a new
level of insight into patients’ progress and new level of
personalisation of treatment. Internet interventions and
short messaging service (SMS) reminders have shown
promising results in enhancing patients’ adherence to
long-term medications [39–41].
Support for carers
The role of carers has grown in importance as support
from friends and family members is a key facilitator of
medication adherence [11]. Many carers are unprepared
for the demands of caring for a chronically ill family
member and will require support and training in the
process of caring for their loved ones. To date, eHealth
has shown moderate effects, for example, on improving
carer stress and depression in caring for people with de-
mentia [42]. Carers of patients with polypharmacy will
likely benefit from peer support, medicine reminders, or-
ganisation, information exchange on medicines and
digital encouragement with the support of eHealth.
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Data analytics
The growing trend of ubiquitous continuous monitoring
via mobile phones, wearables, smart pill boxes, IoT, etc.,
present an opportunity to gain a new level of insight into
a wide range of parameters which directly or indirectly
affect health outcomes. Combined with the data gath-
ered by the health system for an individual as well as
whole populations at the level of the clinic, pharmacy,
hospitals, etc., new predictive models and stratification
approaches will be enabled for more accurate medicines
management [43].
Insights from predictive analytics can already be gener-
ated more readily and at a lower cost. To date, predictive
models have been used to drive risk scores to identify in-
dividuals or sub-populations who are at high risk of
non-adherence to medications in populations with con-
ditions such as HIV [44], hypertension [45], inflamma-
tory bowel disease [46] and diabetes [47]. These models
can identify high-risk populations for further interven-
tions. For instance, an individual belonging to the high-
risk group can be identified as likely to be non-adherent
due to a complex medication regimen requiring frequent
dosing. To improve adherence, therapies could be perso-
nalised such as by changing the medication to reduce
the frequency of doses.
Most studies have relied on regression models with
data derived from cohort studies that surveyed patient
populations on clinical, behavioural and psychosocial
variables relevant to medication adherence. Future
models will go beyond simple regression techniques with
greater deployment of sophisticated data mining tech-
niques such as machine learning. By improving quality,
comprehensiveness of data and bringing together large
numbers of digitally collected data variables, prediction
accuracy will improve.
On the other side, predictive analytics could also be
used by business entities, such as pharmaceutical com-
panies, to improve market intelligence. Leveraging on
mass data, marketing efforts could be personalised and
well-targeted, but such efforts may lead to higher cost to
the patient and healthcare system while at the same time
promote medications or uses that might not be evidence
based. For health insurance companies, it can be argued
that a greater integration of data might facilitate more
accurate prediction of an individual’s cost profile. How-
ever, most jurisdictions, including the US, have moved
towards legislating for community-rated insurance with
all individuals paying the same premium, thereby redu-
cing the potential for providing insurance only for those
at lowest risk.
Although predictive models utilising data from
health IT systems are not new, they are mostly pro-
prietary [48, 49]. In reality, such analytics capabilities
are not yet part of the routine delivery of care. Health
systems are still in the process of learning how to
harness their value to improve healthcare quality [50]
and medication management.
Overcoming barriers to eHealth implementation
Despite the potential for cost-savings and added flexibil-
ity in improving medicines management, challenges in
eHealth implementation must not be disregarded. First,
eHealth implementation requires adequate planning and
consideration of cost-effectiveness [51]. The failure of
the NHS national programme for IT is attributable in
large part to inadequate planning. Ambitious plans to
scale-up the adoption and interconnectivity of EHRs in
the UK backfired when the system was not primed for a
rapid and large scale transformation [52]. eHealth inter-
ventions for medicines management should be piloted
and scaled up progressively. Second, digital literacy is
necessary for the adoption of eHealth. Knowledge of
technology can improve engagement and receptivity to-
wards technological changes, which is crucial for digital
interventions to succeed [53]. Additional training is also
required for specific patient sub-groups to improve their
digital literacy prior to eHealth interventions in medi-
cines management. Third, patient safety must not be
compromised. New technologies may expose users to
unintended risks. In a systematic assessment of 46 insu-
lin dose calculator apps, it was found that the majority
had problems with the data input function, did not val-
idate numeric inputs and displayed incorrect dose re-
sults [54]. Adequate risk management frameworks must
be in place to mitigate potential risks posed to patient
safety. Finally, health data privacy should be reinforced
to increase confidence in eHealth [55]. The widespread
acceptance of eHealth in medicines management will
occur with time, just like its banking and ecommerce
precedents [56], but only when frameworks and secured
encrypted networks provide assurance of security.
While the prospects of eHealth are promising, wide-
scale adoption of eHealth interventions at the population
level requires further significant research, planning,
communication to different population groups and
skilled health IT personnel [57, 58].
Directions for future research
The rapid innovation in eHealth technologies has chal-
lenged policymakers and implementers to find a balance
between evidence-based integration of technologies and
constructive experimentation that could lead to a game-
changing breakthrough [59]. eHealth can impact medi-
cations management at all three levels: macro (at the
level of the healthcare system), meso (clinics, pharma-
cies) and micro (individual patients and carers). At the
micro level, the personalisation of alerts in the way of
regular reminders via mobile phone SMS has been found
Car et al. BMC Medicine  (2017) 15:73 Page 6 of 9
to double the odds of medication adherence [40]. ATCS
was also found to be moderately effective at improving
the monitoring of health outcomes, which positively in-
fluences adherence with medicines. These interventions
have high potential for scaling to routine delivery of
healthcare. This should be accompanied with an ongoing
rigorous evaluation to further improve them (e.g. by fur-
ther personalisation) and create evidence about long-
term effectiveness in real-life. No study of reminders for
medication adherence provides data on long-term (over
several years) effectiveness, acceptability, etc. Yet, if
these interventions are to be embedded in routine deliv-
ery of healthcare these answers are critically needed.
EHR, CDSS and CPOE vary in the level of benefits
they deliver to health systems in the short term and are
challenging to implement at scale. We urgently need
more effective strategies for organisational change that
ensure adoption, not only by enthusiasts, but by all
healthcare professionals alike. We also require rigorous
independent head-to-head studies across a wide range of
eHealth medicines management and other functional-
ities of such systems to inform decision-making related
to their adoption. This information will be of equal rele-
vance to low-, middle- and high-income countries, and
evaluation should allow context-specific interpretation;
the same applies to health apps [54, 60, 61].
Greater use of eHealth to improve health literacy at an
individual and population level is an obvious priority area
for research. There are few, if any, technological barriers
and risks are likely to be minimal. For example, simple so-
lutions for electronic provision of patient education mate-
rials on medications in low- and middle-income countries
where patient education leaflets are not currently provided
have the potential to significantly raise the standard of
care and positively impact health outcomes. These could
be platform-agnostic (i.e. for use on a computer, tablet or
smartphone) text, audio or multimedia-rich depending on
the context, medication prescribed and patient needs.
The transdisciplinary nature of eHealth calls for a team
approach in research that brings multifarious disciplines
together with methodological innovations. Traditional
randomised controlled trial designs may not be suitable,
for example, for evaluation of apps. In many instances, the
technology might already be obsolete by the time the re-
sults are published, let alone implemented at scale. Too
few studies go beyond effectiveness, future eHealth re-
search needs to include and carefully consider, amongst
other dimensions, acceptability, human factors and ergo-
nomics, adoption and adaptability, scalability and fidelity
of interventions at scale (over time and in different con-
texts), sustainability, training needs, safety, patient and
clinician preferences of different backgrounds, and cost-
effectiveness to inform resource allocation decisions at the
micro, meso and macro levels.
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